首页> 外文期刊>Nucleic Acids Research >Mismatch repair and DNA polymerase delta proofreading prevent catastrophic accumulation of leading strand errors in cells expressing a cancer-associated DNA polymerase epsilon variant
【24h】

Mismatch repair and DNA polymerase delta proofreading prevent catastrophic accumulation of leading strand errors in cells expressing a cancer-associated DNA polymerase epsilon variant

机译:不匹配修复和DNA聚合酶DELTA校对防止在表达癌症相关的DNA聚合酶EPSILON变体的细胞中灾难性积累的前导误差

获取原文
获取原文并翻译 | 示例
           

摘要

Substitutions in the exonuclease domain of DNA polymerase epsilon cause ultramutated human tumors. Yeast and mouse mimics of the most common variant, P286R, produce mutator effects far exceeding the effect of Pol epsilon exonuclease deficiency. Yeast Pol epsilon-P301R has increased DNA polymerase activity, which could underlie its high mutagenicity. We aimed to understand the impact of this increased activity on the strand-specific role of Pol epsilon in DNA replication and the action of extrinsic correction systems that remove Pol epsilon errors. Using mutagenesis reporters spanning a well-defined replicon, we show that both exonuclease-deficient Pol epsilon (Pol epsilon-exo(-)) and Pol epsilon-P301R generate mutations in a strictly strand-specific manner, yet Pol epsilon-P301R is at least ten times more mutagenic than Pol epsilon-exo(-) at each location analyzed. Thus, the cancer variant remains a dedicated leading-strand polymerase with markedly low accuracy. We further show that P301R substitution is lethal in strains lacking Pol epsilon proofreading or mismatch repair (MMR). Heterozygosity for pol2-P301R is compatible with either defect but causes strong synergistic increases in the mutation rate, indicating that Pol epsilon-P301R errors are corrected by Pol epsilon proofreading and MMR. These data reveal the unexpected ease with which polymerase exchange occurs in vivo, allowing Pol delta exonuclease to prevent catastrophic accumulation of Pol epsilon-P301R-generated errors on the leading strand.
机译:在的DNA聚合酶的ε-原因核酸外切酶结构域取代ultramutated人类肿瘤。最常见的变体的酵母和鼠标模拟,P286R,产生突变的效果远远超过波尔小量的效果外切酶不足。酵母波尔的ε-P301R增加DNA聚合酶的活性,这可能其背后的高致突变性。我们的目的是了解这种活动增加对DNA复制的波尔小量的链特异性作用的影响和外在校正系统,其捞出波尔小量的错误动作。使用诱变记者跨越定义良好的复制,我们表明,无论是外切酶缺陷波尔小量(POL小量外型( - ))和Pol的ε-P301R生成一个特定的链严格地突变,但波尔的ε-P301R是在至少十倍大于波尔的ε-外型更诱变( - )在每个位置处进行分析。因此,癌症仍然是变体专用前导链聚合酶显着低的精度。进一步的研究表明P301R取代是缺乏波尔小量校对或错配修复(MMR)菌株致死。杂合POL2-P301R是与任一缺陷兼容,但会导致强烈的协同增加的突变率,表明波尔的ε-P301R错误是由波尔小量校对和MMR校正。这些数据揭示与聚合酶交换发生在体内,让波尔三角洲外切酶,以防止在前导链波尔的ε-P301R产生错误的灾难性积累意想不到的缓解。

著录项

  • 来源
    《Nucleic Acids Research》 |2020年第16期|共11页
  • 作者单位

    Univ Nebraska Med Ctr Eppley Inst Res Canc &

    Allied Dis Fred &

    Pamela Buffett Canc Ctr Omaha NE 68198 USA;

    Univ Nebraska Med Ctr Eppley Inst Res Canc &

    Allied Dis Fred &

    Pamela Buffett Canc Ctr Omaha NE 68198 USA;

    Univ Nebraska Med Ctr Eppley Inst Res Canc &

    Allied Dis Fred &

    Pamela Buffett Canc Ctr Omaha NE 68198 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号